Sold by: OneMedNet Corporation
Deployed on AWS
Pancreatic cancer is a malignant disease that develops in the pancreas, a gland located behind the stomach. It is one of the most aggressive and lethal types of cancer. The exact cause of pancreatic cancer is unknown, but several risk factors have been identified.
Pancreatic cancer often doesn't cause symptoms in the early stages. When symptoms do occur, they can be vague and similar to other conditions. It is important to continue to improve early detection for pancreatic cancer.
Overview
Datasets include:
- CT Abdomen/CT CAP/CT AP with portal venous phase of contrast.
- Contrast: Ultravist or Optiray used for imaging.
- Confirmed Diagnosis: Biopsy confirming pancreatic ductal adenocarcinoma (PDAC).
- Imaging: CT or MRI used to rule out other diseases not related to PDAC.
- Lab Results: Indicating autoimmune disease.
- Follow-Up: Imaging done to monitor disease progression, either showing changes or stability.
- This protocol helps in assessing PDAC and other potential conditions through advanced imaging and lab tests.
of Datasets
- 38 studies
Inclusion / Exclusion Criteria
- Normal studies
- Autoimmune pancreatitis
- Benign pancreatic tumore
- Chronic pancreatitis
- Non PDAC pancreatic tumor
- PDAC studies
- Portal Venous phase
- Histology report
- Follow up imaging
- Contrast requirement
- All scanning vendors
- Ages 22-89"
Details
Sold by
Categories
Delivery method
Deployed on AWS
New
Introducing multi-product solutions
You can now purchase comprehensive solutions tailored to use cases and industries.
Features and programs
Financing for AWS Marketplace purchases
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
Pricing
This product is available free of charge. Free subscriptions have no end date and may be canceled any time.
Additional AWS infrastructure costs may apply. Use the AWS Pricing Calculator to estimate your infrastructure costs.
Vendor refund policy
Refunds are not offered for this product.
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA) .
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Additional details
You will receive access to the following data sets.
Data set name | Type | Historical revisions | Future revisions | Sensitive information | Data dictionaries | Data samples |
|---|---|---|---|---|---|---|
Pancreatic cancer_ct_pdac_biopsy_autoimmunepancreatitis_chronic pancreatitis_benign pancreatic tumor | All historical revisions | All future revisions | Not included | Not included |
Resources
Vendor resources
Similar products
This study generated a collection of patient-derived pancreatic normal and cancer organoids and it was sequenced using Whole Genome Sequencing (WGS), Whole Exome Sequencing (WXS) and RNA-Seq as well as matched tumor and normal tissue if available. The study provides a valuable resource for pancreatic cancer researchers.
The dataset contains open RNA-Seq Gene Expression Quantification data and controlled WGS/WXS/RNA-Seq Aligned Reads, WXS Annotated Somatic Mutation, WXS Raw Somatic Mutation, and RNA-Seq Splice Junction Quantification.